Healthcare

signed · Maryland · House of Delegates Apr 28, 2026

HB 772: Behavioral Health Rate Methodology Modernization - Workgroup Establishment and Study

HB 772 establishes a workgroup within Maryland's Health Care Commission to develop fairer reimbursement methods for certified community behavioral health clinics and outpatient mental health centers. The workgroup will study current costs, staffing models, and federal requirements to create transparent, cost-based payment systems, comparing approaches used in other states. It must submit an interim report by December 2026 and a final report by October 2027 with specific recommendations, implementation options, and fiscal estimates. The bill does not require immediate rate changes or new funding, but rather sets a process for future policy decisions based on the workgroup's findings.

Topics ✓ HealthcareSupports HealthcareEstablishes workgroup to develop fairer reimbursement for mental health centers, aiming to improve payment systems and support behavioral health services.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

signed · Maryland · House of Delegates Apr 28, 2026

HB 1533: Public Health - Cosmetic Products - Enforcement and Penalties for Prohibited Ingredients (Crown and Care Act - Protecting Communities from Harmful Hair Chemicals)

HB 1533 (the Crown and Care Act) bans 12 specific harmful ingredients - including certain phthalates, formaldehyde, mercury, and PFAS chemicals - from cosmetic products sold in Maryland. It directly affects cosmetic manufacturers, retailers, and salons by prohibiting the sale or distribution of products containing these ingredients, with limited exceptions for unavoidable trace amounts from manufacturing processes. The bill authorizes the Maryland Department of Health to investigate complaints, inspect businesses, and enforce penalties, while allowing consumers harmed by violations to seek civil damages and attorney fees. This law aims to protect public health by reducing exposure to chemicals linked to health risks like skin irritation and potential long-term harm.

Topics ✓ EnvironmentSupports EnvironmentBans PFAS and other environmental pollutants (known to contaminate water/soil) from cosmetics, reducing chemical pollution in ecosystems per bill's prohibition of harmful ingredients.85% confidence ✓ HealthcareSupports HealthcareBans harmful cosmetic chemicals (phthalates, formaldehyde, etc.) to prevent health risks, directly protecting public health through regulatory enforcement by MD Dept of Health.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

signed · Maryland · House of Delegates Apr 28, 2026

HB 1192: State Board of Sign Language Interpreters - Membership and Licensing

HB 1192 expands Maryland's State Board of Sign Language Interpreters from 7 to 11 members, requiring specific representation including deaf individuals, deafblind people, licensed interpreters from various settings (medical, legal, educational), and agency owners. The bill delays the deadline for the Board to establish licensing requirements from July 1, 2024, to December 31, 2026, and sets new rules for member removal if they miss meetings, fail to meet qualifications, or commit misconduct. Sign language interpreters in Maryland who provide services in the state will be directly affected by the updated licensing requirements and the Board's new structure. The bill also mandates that appointed members reflect Maryland's racial and geographic diversity where practicable.

Topics ✓ HealthcareSupports HealthcareBill requires medical interpreter representation on licensing board, improving healthcare access for deaf patients in medical settings per healthcare topic definition.85% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

signed · Maryland · Senate Apr 28, 2026

SB 645: State Board of Sign Language Interpreters - Membership and Licensing

SB 645 restructures Maryland's State Board of Sign Language Interpreters by expanding its membership from seven to 11 members with specific representation requirements, including a deafblind individual, deaf community members, licensed interpreters from various settings (legal, medical, educational), and ex-officio members from disability and labor agencies. The bill requires the Board to establish licensing requirements for sign language interpreters by December 31, 2026 (previously July 1, 2024), and mandates interpreters to meet these standards by that date. It also adds new grounds for the Governor to remove board members, including two consecutive unexcused absences or failing to attend 50% of meetings annually. These changes aim to improve board diversity, clarify licensing timelines, and ensure board members meet ongoing eligibility criteria.

Topics ✓ HealthcareSupports HealthcareRequires licensing for medical interpreters (explicitly cited in bill), improving access to healthcare services for deaf patients in medical settings.85% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

signed · Maryland · Senate Apr 28, 2026

SB 656: Public Health - Cosmetic Products - Enforcement and Penalties for Prohibited Ingredients (Crown and Care Act - Protecting Communities from Harmful Hair Chemicals)

SB 656 bans 12 specific harmful chemicals in cosmetics sold in Maryland, including formaldehyde, mercury, and certain PFAS chemicals. It creates civil liability for manufacturers or sellers who violate this ban, allowing consumers to sue for damages. The Maryland Department of Health gains authority to investigate complaints, inspect businesses, and collect product samples. The law exempts trace amounts of banned ingredients that occur unavoidably during manufacturing. The bill takes effect July 1, 2026.

Topics ✓ EnvironmentSupports EnvironmentBans PFAS and toxic chemicals (pollution sources) in cosmetics, reducing environmental contamination and strengthening regulatory controls.95% confidence ✓ HealthcareSupports HealthcareBans harmful cosmetic chemicals (formaldehyde, mercury, PFAS) to prevent health risks, directly advancing public health protection under healthcare policies.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

signed · Maryland · House of Delegates Apr 28, 2026

HB 1483: Clinical Professional Counseling - Out-of-State Providers - Use of Telehealth for Continuity of Care

HB 1483 repeals Maryland's requirement for out-of-state clinical counselors to obtain a temporary telehealth license. It allows licensed counselors from other states to provide telehealth counseling to clients who relocated to Maryland (or returned after relocating), for up to six months, if they already had an established client-counselor relationship before the move. This exempts these counselors from Maryland's standard licensure rules during the six-month continuity period, but only for existing clients who relocated - not for new clients. The bill does not change regular licensing requirements for ongoing practice in Maryland.

Topics ✓ HealthcareSupports HealthcareRemoves licensure barrier for out-of-state counselors providing telehealth mental health services, improving access for relocated clients during continuity period.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

signed · Maryland · House of Delegates Apr 28, 2026

HB 1135: Health Occupations - Pharmacists - Vaccination Orders

HB 1135 allows pharmacists in Maryland to order certain vaccinations for patients aged 3 and older without needing to administer the vaccine themselves. Pharmacists must complete 20+ hours of approved training covering vaccine safety, injection techniques, and emergency response, hold current CPR certification, and report all vaccinations to the ImmuNet program. The bill specifically covers influenza, COVID-19, and emergency-use vaccines, and requires pharmacists to refer minors to pediatric care when ordering vaccines. This expands pharmacists' role in vaccine access while maintaining safety protocols and reporting requirements.

Topics ✓ HealthcareSupports HealthcareExpands pharmacist authority to order vaccines for patients 3+, increasing access to public health services and aligning with vaccination coverage goals without physician oversight.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

signed · Maryland · Senate Apr 28, 2026

SB 773: Health Occupations - Pharmacists - Vaccination Orders

SB 773 allows pharmacists in Maryland to order certain vaccinations (like flu, COVID-19, or emergency vaccines) for patients aged 3 and older without needing to administer the vaccine themselves. To qualify, pharmacists must complete 20 hours of approved training, hold current CPR certification, and complete 2 hours of continuing education on immunizations. The bill requires pharmacists to follow written vaccine-specific protocols, report all vaccinations to Maryland’s ImmuNet registry, and refer pediatric patients to primary care providers when appropriate. This policy directly affects pharmacists, patients seeking these vaccines, and healthcare coordination for immunizations. The changes take effect October 1, 2026.

Topics ✓ HealthcareSupports HealthcareExpands pharmacist authority to order vaccinations, improving patient access to immunizations without physician referral while maintaining safety protocols.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

signed · Maryland · Senate Apr 28, 2026

SB 915: State Board of Physicians - Delegation of Duties - Alterations

SB 915 requires individuals performing limited X-ray procedures (such as chest, spine, and limb imaging) in Maryland to register with the State Board of Physicians. It restricts these operations to non-invasive X-rays only (excluding CT scans, mammography, or fluoroscopy) and mandates 115 hours of specialized training plus 6 months of clinical experience. The bill also establishes disciplinary procedures for violations and allows physician assistants to perform X-ray duties under physician supervision, while updating rules for cardiovascular specialists and medical graduates. This directly affects medical staff, radiologic technicians, and physician assistants conducting basic X-ray services in clinical settings.

Topics ✓ HealthcareSupports HealthcareRequires training and registration for X-ray technicians to ensure safety and professional standards, enhancing patient care quality within healthcare services.85% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

signed · Maryland · Senate Apr 28, 2026

SB 778: Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

SB 778 creates a new "clinical research pharmacy permit" required for pharmacies conducting clinical trials in Maryland. It allows healthcare providers to own such pharmacies under specific conditions, including requiring a licensed pharmacist to be on-site at all times and prohibiting owners from receiving payment for patient referrals. The bill also exempts clinical trials conducted by corporations from being classified as "practice of medicine," removing a licensing barrier for these activities. This directly affects pharmacies seeking to operate clinical trials, healthcare providers considering ownership, and the State Board of Pharmacy (as the permit issuer).

Topics ✓ HealthcareSupports HealthcareRemoves licensing barrier for clinical trials by exempting corporate trials from 'practice of medicine' classification, enabling research pharmacies to operate and advance medical innovation and patient access to trials.90% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare